Cargando…
The cost and challenge of vaccine development for emerging and emergent infectious diseases
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129672/ https://www.ncbi.nlm.nih.gov/pubmed/30342926 http://dx.doi.org/10.1016/S2214-109X(18)30418-2 |
| _version_ | 1783516838715457536 |
|---|---|
| author | Maslow, Joel N |
| author_facet | Maslow, Joel N |
| author_sort | Maslow, Joel N |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7129672 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | The Author(s). Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71296722020-04-08 The cost and challenge of vaccine development for emerging and emergent infectious diseases Maslow, Joel N Lancet Glob Health Comment The Author(s). Published by Elsevier Ltd. 2018-12 2018-10-18 /pmc/articles/PMC7129672/ /pubmed/30342926 http://dx.doi.org/10.1016/S2214-109X(18)30418-2 Text en © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Maslow, Joel N The cost and challenge of vaccine development for emerging and emergent infectious diseases |
| title | The cost and challenge of vaccine development for emerging and emergent infectious diseases |
| title_full | The cost and challenge of vaccine development for emerging and emergent infectious diseases |
| title_fullStr | The cost and challenge of vaccine development for emerging and emergent infectious diseases |
| title_full_unstemmed | The cost and challenge of vaccine development for emerging and emergent infectious diseases |
| title_short | The cost and challenge of vaccine development for emerging and emergent infectious diseases |
| title_sort | cost and challenge of vaccine development for emerging and emergent infectious diseases |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129672/ https://www.ncbi.nlm.nih.gov/pubmed/30342926 http://dx.doi.org/10.1016/S2214-109X(18)30418-2 |
| work_keys_str_mv | AT maslowjoeln thecostandchallengeofvaccinedevelopmentforemergingandemergentinfectiousdiseases AT maslowjoeln costandchallengeofvaccinedevelopmentforemergingandemergentinfectiousdiseases |